Studies on the Human Dbl Oncogene Product

Srivastava, Shiv

Abstract

Funding Agency

• Agency: National Institute of Health (NIH)
• Institute: National Cancer Institute (NCI)
• Type: First Independent Research Support & Transition (FIRST) Awards (R29)
• Project #: 1R29CA046455-01
• Application #: 3458619
• Study Section: Pathology B Study Section (PTHB)
• Project Start: 1988-03-01
• Project End: 1988-09-09
• Budget Start: 1988-03-01
• Budget End: 1988-09-09
• Support Year: 1
• Fiscal Year: 1988

Institution

• Name: Georgetown University
• Type: Schools of Medicine
• DUNS #: 049515844
• City: Washington
• State: DC
• Country: United States
• Zip Code: 20057

Publications

Srivastava, S; Wang, S; Tong, Y A et al. (1993) Several mutant p53 proteins detected in cancer-prone families with Li-Fraumeni syndrome exhibit transdominant effects on the biochemical properties of the wild-type p53. Oncogene 8:2449-56

Graziani, G; Nebreda, A R; Srivastava, S et al. (1992) Induction of Xenopus oocyte meiotic maturation by the dbl oncogene product. Oncogene 7:229-35

Graziani, G; Ron, D; Eva, A et al. (1989) The human dbl-proto-oncogene product is a cytoplasmic phosphoprotein which is associated with the cytoskeletal matrix. Oncogene 4:823-9

Ruggiero, M; Srivastava, S K; Fleming, T P et al. (1989) NIH3T3 fibroblasts transformed by the dbl oncogene show altered expression of bradykinin receptors: effect on inositol lipid turnover. Oncogene 4:767-71